| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Clinical and Molecular Hepatology |
2025―Mar―05 |
Reply to correspondence on “The Burden of Steatotic Liver Disease before and during the COVID Pandemic” |
Jeayeon Park, Su Jong Yu |
| 2 |
[GO] |
Clinical and Molecular Hepatology |
2025―Feb―17 |
The Burden of Steatotic Liver Disease before and during the COVID Pandemic Correspondence to editorial on “Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD in the COVID-19 pandemic (CMH-2025-0019)” |
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed |
| 3 |
[GO] |
Clinical and Molecular Hepatology |
2025―Jan―16 |
Revealing the Importance of a Multidisciplinary Approach to Reducing the Global Burden of SLD Through the COVID-19 Pandemic: Editorial on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023” |
Jeayeon Park, Su Jong Yu |
| 4 |
[GO] |
Clinical and Molecular Hepatology |
2024―Aug―29 |
Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multi-nationwide cohort study from South Korea, Japan, and the UK |
Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Myeongcheol Lee, Hyeon Jin Kim, Yejun Son, et al. (+7) Sang Youl Rhee, Lee Smith, Masoud Rahmati, Jiseung Kang, Hayeon Lee, Yeonjung Ha, Dong Keon Yon |
| 5 |
[GO] |
Clinical and Molecular Hepatology |
2024―Aug―06 |
From Past to Pandemic: Health Disparities in U.S. Hepatobiliary Cancer Mortality Before and During COVID-19 |
Ilona Argirion |
| 6 |
[GO] |
Clinical and Molecular Hepatology |
2022―Nov―10 |
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: reply |
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen |
| 7 |
[GO] |
Clinical and Molecular Hepatology |
2022―Oct―31 |
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: Correspondence |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 8 |
[GO] |
Clinical and Molecular Hepatology |
2022―Sep―13 |
Forms of cholangitis to be considered after SARS-CoV-2 infection |
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim |
| 9 |
[GO] |
Clinical and Molecular Hepatology |
2022―Sep―06 |
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study |
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung |
| 10 |
[GO] |
Clinical and Molecular Hepatology |
2022―Jun―03 |
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: a meta-analysis |
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ricky R Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen |
| 11 |
[GO] |
Clinical and Molecular Hepatology |
2021―Sep―17 |
Update on Liver Disease Management During the Pandemic of Coronavirus Disease 2019 (COVID-19): KASL 2021 Guidance |
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim |
| 12 |
[GO] |
Clinical and Molecular Hepatology |
2020―Oct―07 |
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea |
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, et al. (+9) Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park |
| 13 |
[GO] |
Clinical and Molecular Hepatology |
2020―Jun―23 |
Management of liver diseases during the pandemic of coronavirus disease-19 |
Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim |
